15 September 2022>: Clinical Research
Endobiliary Ablation Combined with Immune Nutrition Improves Quality of Life: A Preliminary Clinical Study in Patients with Advanced Malignant Obstructive Jaundice
Jie Yao 1ABE , Yalin Kong 2A* , Cheng Wang 2C , Yaping Wei 1BD , Hailian Li 1DE , Chengli Liu 23DEF*DOI: 10.12659/MSM.936863
Med Sci Monit 2022; 28:e936863
Table 3 Primary outcome of the studied groups.
Variables | Control group (n=28) | Study group (n=31) | P value |
---|---|---|---|
Resume daily activities (day) | 15.8±6.3 | 16.9±6.7 | 0.741 |
Excluding censored cases (day) | 12.1±4.1 | 13.7±5.4 | 0.263 |
Duration of stent patency (month) | 7.0±3.7 | 10.6±4.1 | 0.015* |
Death (n) | 23 (82.1%) | 24 (77.4%) | 0.168 |
Tumor progression | 21 (75.0%) | 16 (45.7%) | 0.249 |
Non-tumor progression | 3 (9.3%) | 7 (31.5%) | 0.012 |
Overall survival (month) | 7.4±2.6 | 10.1±3.4 | 0.017* |
* |